Niagen Bioscience NAGE Ratios (2010-2026)

NASDAQ NAGE
$2.13 -0.14 (-6.36%)
As of: Nov 10, 2026 · 3:15 PM EST
Reported Financials

Niagen Bioscience Quarterly Ratios

Periods 61 quarters
Latest Sep 2026

Niagen Bioscience reported a gross margin of 62.90% and a net margin of -4.31% for the quarter ended Sep 2026. These financial ratios cover 61 quarters of results from Oct 2010 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Oct2010 Apr2011 Jul2011 Oct2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Mar2014 Jun2014 Sep2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Profitability
Gross Margin
61.20%61.02%60.02%59.82%57.23%59.93%60.80%61.40%61.04%60.74%60.22%63.49%62.48%63.42%65.00%64.52%64.14%63.47%64.84%62.90%
EBT Margin
-29.98%-44.85%-38.23%-17.99%-6.88%-8.72%-11.40%-5.88%-0.79%-2.22%-0.07%7.34%25.70%17.16%12.01%14.12%13.07%21.40%3.59%-4.31%
EBIT Margin
-29.93%-44.80%-38.17%-17.96%-6.88%-8.72%-11.40%-5.88%-0.79%-3.30%-1.13%6.26%24.42%15.66%10.24%12.46%12.07%5.01%2.35%-5.84%
EBITDA Margin
-28.46%-43.35%-36.61%-16.33%-5.62%-7.53%-10.06%-4.49%0.23%-2.32%-0.22%7.05%25.06%16.30%10.87%13.04%12.66%5.93%3.33%-4.77%
Operating Margin
-29.93%-44.80%-38.17%-17.96%-6.88%-8.72%-11.40%-5.88%-0.79%-3.30%-1.13%6.26%24.42%15.66%10.24%12.46%12.07%5.01%2.35%-5.84%
Net Margin
-29.98%-44.85%-38.23%-5.77%-6.75%-8.43%-10.78%-4.92%0.54%-2.22%-0.07%7.34%24.65%16.61%11.60%13.47%12.06%20.07%3.23%-4.31%
FCF Margin
-27.85%-41.85%-23.41%-22.22%-2.38%11.97%16.09%1.90%2.96%1.15%-1.21%13.50%29.23%25.76%3.58%10.79%1.71%-3.99%9.01%9.46%
Efficiency
Inventory AverageInventory Avg.
13.14M14.45M15.53M15.69M15.16M13.29M11.94M12.30M13.57M13.51M12.00M11.03M9.87M10.19M12.80M16.60M
Assets AverageAssets Avg.
59.15M55.39M49.77M46.14M49.86M53.91M53.47M53.33M54.22M54.52M54.06M55.28M62.40M74.81M86.43M94.83M102.27M110.37M110.46M107.64M
Equity AverageEquity Avg.
33.59M28.80M23.33M20.90M24.85M28.34M27.58M27.23M27.88M28.70M29.83M32.54M40.23M50.72M59.77M67.44M73.60M79.43M82.43M82.80M
Invested CapitalInvested Cap.
Asset Utilization RatioAsset Util.
1.141.261.391.491.451.431.511.561.541.531.581.661.601.441.351.321.271.181.171.14
Leverage & Solvency
Interest Coverage RatioInterest Cover
-590.67-966.50-638.70-613.00
Debt Ratio
Times Interest Earned
-590.67-966.50-638.70-613.00
Valuation
Price to EarningsP/E
186.8748.0338.3764.6936.3729.2518.8515.7922.54
Price to SalesP/S
3.782.391.651.221.741.481.451.311.283.142.413.034.125.019.865.963.922.691.951.89
Price to BookP/B
8.036.485.483.994.374.084.334.013.779.036.718.078.919.7817.8610.516.624.263.052.78
Enterprise Value
226.57M146.65M96.75M70.59M104.83M91.10M91.12M82.60M79.90M233.97M178.16M245.10M365.96M485.57M1,086.36M678.74M442.19M283.86M184.98M161.26M
EV to EBIT
548.3247.3736.7165.1735.1627.1621.7017.4533.77
EV to EBITDA
190.3042.8534.6362.2533.8025.9120.3315.9827.58
Market Capitalization
254.79M167.65M113.82M83.85M125.27M114.24M117.52M109.37M107.22M261.53M206.04M277.50M410.62M541.19M1,146.83M743.03M506.98M350.41M251.72M230.77M
Price to FCFP/FCF
70.0018.7215.3957.84211.1168.3534.3727.6954.7835.1338.3785.3444.3650.40
EV to FCF
54.2714.1411.4651.74182.5460.3730.6324.8551.8932.0933.4769.1332.6035.22
EV to CFO
45.4713.4511.2350.64165.5758.7130.2224.6551.2231.7132.7564.1231.0933.03
Return Ratios
Return on Sales [ROS]ROS
-29.93%-44.80%-38.17%-17.96%-6.88%-8.72%-11.40%-5.88%-0.79%-3.30%-1.13%6.26%24.42%15.66%10.24%12.46%12.07%5.01%2.35%-5.84%
Return on Capital Employed [ROCE]ROCE
-65.18%-74.79%-88.23%-76.50%-58.23%-36.25%-25.55%-20.29%-16.66%-12.44%-6.36%1.19%17.38%24.51%26.00%26.77%19.77%14.94%11.11%5.26%
Return on Assets [ROA]ROA
-45.87%-49.63%-56.90%-48.84%-37.41%-23.89%-16.45%-12.89%-10.33%-7.56%-3.37%2.18%13.70%18.86%20.51%21.54%17.00%16.89%14.48%9.51%
Return on Equity [ROE]ROE
-80.77%-95.43%-121.39%-107.81%-75.06%-45.44%-31.90%-25.25%-20.08%-14.36%-6.11%3.70%21.25%27.81%29.66%30.29%23.62%23.46%19.40%12.37%

Niagen Bioscience Ratios API

Pull Niagen Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NAGE&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY